Skip to main content
Clinical Trials/ACTRN12619001475134
ACTRN12619001475134
Completed
Phase 2

PRECeDe Pilot: Prevention of neonatal Respiratory distress with antenatal corticosteroids prior to Elective Caesarean section in women with Diabetes - A Feasibility Randomised Trial

Western Health0 sites47 target enrollmentOctober 24, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes
Sponsor
Western Health
Enrollment
47
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 24, 2019
End Date
June 8, 2022
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women with a singleton or twin pregnancy between 35\+0 and 38\+6 weeks who have pre\-gestational diabetes OR gestational diabetes (diagnosed on a pregnancy 75g Oral glucose tolerance test according to the WHO criteria for gestational diabetes)
  • plan to give birth by elective caesarean section within the next 7 days.

Exclusion Criteria

  • 1\.Known major fetal anomaly or chromosomal anomaly.
  • 2\.Administration of any corticosteroid therapy within the last 7 days.
  • 3\.Contraindication to corticosteroids

Outcomes

Primary Outcomes

Not specified

Similar Trials